. The acute signalling events triggered by ET-1 presumably lead to the changes in gene/protein expression associated with cardiac myocyte hypertrophy or cell cycle progression in proliferating cells. However, activation of intracellular signalling elements such as PKC and ERK1/2 occurs rapidly and, at least in cardiac myocytes, this activation is transient. Thus, activation of ERK1/2 by ET-1 in cultured cardiac myocytes is maximal at ~5 min, returning almost to basal levels within ~30 min Clerk et al., 1996) . How these early transient signals are propagated and lead to the phenotypic responses over many hours or even days is not often considered.
Regulation of gene expression by ET-1.
In any cellular response, activation of pre-existing transcription factors (TFs) downstream of intracellular signalling events leads to the increased expression IEGs.
Because IEG expression is driven by pre-existing TFs, there is no requirement for de novo protein synthesis and the response is not inhibited by protein synthesis inhibitors such as cycloheximide. Some IEGs encode "structural" proteins such as ion channels or components of the cytoskeleton which directly influence the cellular phenotype. However, many IEGs constitute a "regulatory" component, encoding transcriptional regulators including TFs. At least some of the IEGs encode negative regulators of gene expression which feed back to limit the IEG response, whereas other combinations of TFs regulate downstream, secondphase gene expression. Since second phase genes require synthesis of IEG proteins, this phase of the response is inhibited by cycloheximide. In contrast, preventing the expression of a negative feedback protein by cycloheximide results in enhanced expression of IEG mRNAs. Potentially, second phase TFs regulate expression of third-phase genes further downstream, etc. (see Fig. 1 and (Clerk et al., 2007a) ). As the response progresses, the A. Clerk 4 proportion of "regulatory" to "structural" proteins declines as the new steady-state phenotype develops. Throughout this time, cells remain responsive to the environment although the response is probably modulated by changing expression of cell surface receptors and intracellular signalling components. The cells also influence the environment by producing extracellular matrix components and secreted factors which signal to other cells in the vicinity.
IEGs (e.g. c-fos, c-jun, egr1) are upregulated in cardiac myocyte hypertrophy (Dorn et al., 2003; Sugden and Clerk, 1998) , and it is assumed that they regulate expression of hypertrophic genes including classical markers of hypertrophy (e.g. atrial natriuretic factor, ANF). However, our knowledge has previously been limited to a few established IEGs and it is not clear how the expression of these genes/proteins leads hypertrophy. To start to clarify these issues, we have been using microarrays to determine the changes in gene expression induced by ET-1 in primary cultures of neonatal rat ventricular cardiac myocytes (NRVMs) over the first 4 h (as the initial phases of the response develop) and to distinguish IEGs from downstream gene expression (Cullingford et al., 2008b) . Our data demonstrate a multiphasic response consistent with the model described above and in Fig. 1 . Early IEGs are induced within 30 min, with later IEGs appearing at 1 -2 h. Surprisingly, the earliest of the second phase genes are detected within 1 h. At these early times, many of the genes are associated with transcriptional regulation or with intercellular or intracellular signalling and are not classically associated with hypertrophy. This indicates that this phase is an intermediate stage in the response. Several families of TFs were subject to regulation by ET-1 within the first hour, and these may be "master-switches" for downstream gene regulation. For example, there are significant changes in expression of many of the Krüppel-like factors (Klfs), suggesting that Klfs play a major role in the response (Cullingford et al., 2008a; Cullingford et al., 2008b) . One example of a potential feedback inhibitor of IEG expression is activating transcription factor 3 (Atf3) which is implicated in downregulation of expression of interleukin 6 (IL6) in the context of endotoxin-induced inflammation (Gilchrist et al., 2006) . Here, we present data for the regulation of three IEGs which are responsive to ET-1 in cardiac myocytes: Atf3, Klf2 and IL6.
Materials and methods

Preparation of neonatal cardiac myocytes and adenoviral infection
Myocytes were dissociated from the ventricles of neonatal Sprague-Dawley rat hearts using collagenase and pancreatin as previously described (Iwaki et al., 1990; Bogoyevitch et al., 1995) . Non-myocytes were removed by pre-plating onto uncoated tissue culture dishes (30 min, 37/C). The (non-adherent) cardiac myocytes were collected and plated in serumcontaining medium at a density of 1.4 × 10 3 cells/mm 2 on Primaria tissue culture dishes precoated with 1% (w/v) gelatin. After 18 h, serum was withdrawn for 24 h prior to use.
Agonists were added directly to the tissue culture medium. For adenoviral infection, cardiac myocytes were serum-starved for 4 h before adding 200 :l of virus stock in PBS to the medium. Cardiac myocytes were incubated for a further 48 h before experimentation.
Semi-quantitative and quantitative reverse transcriptase polymerase chain reaction (RT-PCR)
RNA was prepared and semi-quantitative RT-PCR performed as previously described (Clerk et al., 2007b) , using 100 pmol forward and reverse primers as follows: Atf3 (accession no. NM_012912): forward 5'-GCTGCCAAGTGTCGAAACAAG -3', reverse For Atf3 and IL6, samples were subjected to 27 cycles of amplification. Bands were detected under UV light and sizes were estimated by comparison to a NX174 RF DNA Hae III digest DNA ladder (ABgene) or a 100 bp ladder (Invitrogen). Densitometric analysis was performed using Imagemaster 1D Prime, version 3.0 (GE Healthcare).
Quantitative PCR (QPCR) was performed using a 7500 Real-Time PCR System forward 5'-GATCATCCAGTCCAGCAATG-3', reverse 5'-TATTCTGGCTATGCAGTTCAG -3', 140 bp product).
Western blotting
Cardiac myocyte nuclear extracts were prepared and immunoblotted as described previously (Markou et al., 2008) . Blots were probed with primary rabbit polyclonal antibodies specific for Atf3 (Santa Cruz Biotechnology Inc., Cat. no. sc-188; 1/1000 dilution)
or Atf2 (Santa Cruz Biotechnology Inc., Cat. no. sc-187; 1/1000 dilution), followed with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulins (DakoCytomation; 1/5000 dilution). Immunoreactive bands were detected by enhanced chemiluminescence (Santa-Cruz Biotechnology Inc.) and the bands analysed by semi-quantitative scanning densitometry (Imagemaster 1D Prime version 3.0).
Chromatin immunoprecipitation (ChIP)
Following stimulation 
Production and preparation of adenoviruses
Replication-deficient adenoviruses expressing full-length rat Atf3 antisense RNA (AS-Atf3) or shRNA for Klf2 were prepared using the AdEasy™ XL Adenoviral Vector System (Stratagene). For Atf3, the coding sequence was isolated by PCR from rat cDNA using Pfu polymerase and primers designed to the 5' ATG start site and 3' stop codon regions. Primers were designed to include sites for restriction enzymes for insertion into the multiple cloning site of the pShuttle-CMV vector. Control samples were prepared with empty vector. For Klf2 knockdown by siRNA, pShuttle vectors were prepared containing shRNA-generating U6 promoter and annealed oligodeoxynucleotides for Klf2 shRNA. A 19 base sequence for an siRNA-generating construct against Klf2 (5'-AGACCTACACCAAGAGTTC-3') was selected using the siRNA Target Finder and Design tool (www.ambion.com/techlib/misc/siRNA_finder.html), siDESIGN center (http://www.dharmacon.com/designcenter/DesignCenterPage.aspx), and based on Lim et al., 2005 . A random control sequence was also used (5'-ATGAACGTGAATTGCTCAA-3'; targeted to luciferase (Dekker et al., 2005) 
Results and Discussion
Identification of candidate IEG mRNAs likely to be subject to negative feedback regulation by IEG proteins.
We previously identified 45 IEG mRNAs upregulated in cardiac myocytes by ET-1 Fig. 2 (100 nM) within 30 min of stimulation (i.e. early IEGs) (Cullingford et al., 2008b) . To identify IEG mRNAs which may be under negative feedback control by other IEG proteins, we selected mRNAs which were maximally upregulated at 0.5 -1 h but whose expression decreased by 2 h (Table 1) 2). Of these, Atf3 negatively regulates its own expression (Wolfgang et al., 2000) and suppresses expression of IL6 induced in macrophages by lipopolysaccharide (Gilchrist et al., 2006) . Klf2 is also implicated in negative regulation of IEG expression (Amit et al., 2007) .
We therefore focused on the potential role of Atf3 and Klf2 in termination of IEG expression. 
Regulation of expression of Atf3 and IL6 in cardiac myocytes.
We validated the microarray data for Atf3 and IL6 using semi-quantitative RT-PCR. ET- 1 (100 nM) promoted a very rapid (within 15 min) and potent increase in Atf3 mRNA expression in cardiac myocytes, with maximal expression at ~0.5 h (Fig. 3A ). An increase in protein expression was detected within 1 h of stimulation (data not shown). In a previous microarray study, we also detected simultaneous increases in expression of Atf3 and IL6 in cardiac myocytes by H 2 O 2 (as an oxidative stress) (Clerk et al., 2007c) . The upregulation of Atf3 in response to 0.2 mM H 2 O 2 (Fig. 3B ) was delayed relative to that induced by ET-1, with maximal expression of the mRNA at 1 -2 h and maximal protein expression at ~2 h (data not shown). IL6
mRNA expression was rapidly increased by either ET-1 (Fig. 3C ) or H 2 O 2 ( Fig. 3D ) with similar kinetics for upregulation as Atf3 (Fig. 3, A and B) . However, downregulation of IL6 mRNA appeared to be more rapid than that of Atf3 mRNA with almost complete attenuation of the response to ET-1 within 1 h.
To determine whether the increase in Atf3 expression induced by ET-1 downregulates the increase in expression of IL6 in cardiac myocytes, cardiac myocytes were infected with adenoviruses encoding full-length antisense RNA to Atf3 to prevent the increase in expression of Atf3 mRNA. With this system, we obtained ~70% inhibition of the increase in Atf3 protein induced by ET-1 (Fig. 4A) . The knockdown of Atf3 was specific since there was no effect on expression of the related transcription factor Atf2 (Fig. 4A) . Consistent with the proposed role for Atf3 in inhibiting IL6 mRNA expression, knockdown of Atf3 protein by antisense RNA caused superinduction of IL6 mRNA expression by ET-1 (Fig. 4B) . We hypothesized that other IEG mRNAs may be subject to regulation by Atf3 in a similar manner as IL6. Of the IEGs we identified (Table 1) , Ereg and Lif showed the most similar pattern to IL6 for increased expression by ET-1 and enhancement of expression by cycloheximide (Fig. 2) . Interestingly, of the genes tested, Atf3 antisense RNA enhanced the increase in expression of Ereg (Fig. 4C) and Lif (Fig. 4D ), but not c-Jun (Fig. 4E ), c-Fos or Ier2 (data not shown). An Atf3 consensus sequence has been identified in the mouse IL6 promoter (Gilchrist et al., 2006) . A similar sequence is present in the rat IL6 promoter (Fig. 5, A and B) . To determine whether Atf3 may exert a direct negative regulatory effect on IL6 transcription by binding to this sequence, we used chromatin immunoprecipitation (ChIP) with antibodies to Atf3 to isolate DNA fragments associated with the protein and performed RT-PCR across the putative binding site in the IL6 promoter (Fig. 5B) . ET-1 did indeed increase the association of Atf3 with the IL6 promoter at 1 h (Fig. 5C ), indicating that Atf3 acts directly on the IL6 promoter to downregulate its mRNA expression.
Regulation of Klf2 and its potential role in downregulating IL6 expression.
Of the other IEGs in our selected group, Klf2 also negatively regulates IEG mRNA expression (Amit et al., 2007) . Like Atf3, expression of Klf2 mRNA is detected very rapidly (within 15 min) with maximal expression at ~30 min and expression levels decline thereafter (Cullingford et al., 2008a) . To investigate the role of Klf2 in downstream signalling, cardiac myocytes were infected with adenoviruses encoding shRNA for siRNA knockdown of Klf2 expression prior to stimulation with ET-1. We obtained ~56% inhibition of Klf2 mRNA expression in the absence of any effect on the related protein Klf6 (Fig. 6A) . Interestingly, knockdown of Klf2 enhanced the increase in expression of IL6 (Fig. 6B) or Ereg (data not shown) induced by ET-1 in the absence of any effect on Ptgs2 (cyclooxgenase 2). Both IL6 (Fig.   5A ) and Ereg promoter regions contain consensus binding sites for Klfs. It remains to be determined whether Klf2 directly binds to the promoters to inhibit expression of IL6 or Ereg, or if the effect may be indirect.
The role of negative feedback on IL6 expression in modulating cardiac function.
IL6 family cytokines (which includes cardiotrophin-1 and Lif) stimulate gp130 receptors (Müller-Newen, 2003) to activate JAK/STAT signalling and signalling through the ERK5
cascade (Heinrich et al., 2003) . Cardiotrophin 1 or Lif act via gp130 receptors to promote a form of cardiac myocyte hypertrophy in which sarcomeres are laid down in series rather than in parallel, resulting in myocyte elongation (Wollert et al., 1996; Nicol et al., 2001) . However, serum levels of IL6 are elevated in pathological hypertrophy, and high, sustained expression of IL6 may contribute to the development of heart failure (Mann, 2003) . It is therefore possible that part of the response induced by ET-1 may be mediated by IL6. However, limiting its production is probably necessary to prevent the deterioration of cardiac function associated with high level, sustained production of IL6. Thus, negative feedback modulators such as Atf3 and Klf2 are potentially key components of a system designed to facilitate the beneficial aspects of cardiac myocyte hypertrophy. Dysregulation of these systems may contribute to the development of heart failure.
Summary
Overall, our studies are consistent with Atf3 acting directly on the IL6 promoter to inhibit further transcription of IL6 mRNA following stimulation with ET-1, given that Atf3 protein binds directly to the promoter (Fig. 5) and knockdown of the protein enhances IL6 mRNA expression (Fig. 4) . Klf2 also appears to operate in a negative feedback system to limit IL6 mRNA expression since its knockdown also enhances IL6 mRNA expression (Fig. 6) , although further studies are required to determine whether its effects are directly mediated at the level of the IL6
promoter. Interestingly, Ereg appears to be co-regulated with IL6 with a similar pattern of expression in response to ET-1 and similar enhancement of expression by cycloheximide (Fig. 2), Atf3 knockdown (Fig. 4) or Klf2 knockdown (Fig. 5) . However, for both IL6 and Ereg, other factors may further contribute to the downregulation of mRNA expression following the increase induced by ET-1, possibly by increasing its rate of degradation. It is interesting that ET-1 also increased expression of Zfp36 (Table 1) which is associated with regulation of mRNA stability (Carrick et al., 2004) . This and other factors may be required to limit the expression of IL6, Ereg and other selected IEGs responding to stimuli such as ET-1, and ensure that they are expressed only transiently. Understanding how these early changes associated with intercellular or intracellular signalling and gene/protein expression relate to the changing environment of a cell will help us understand how a complex phenotypic response such as cardiac hypertrophy may develop in vivo and how such an initially beneficial response may deteriorate into (for the heart) cardiac failure. 
